OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

In February, the company partnered with the US Anti-Doping Agency (USADA) to use its wearable sweat-collection device, ...

The increases were particularly marked among middle-aged men, Black adults, residents of Midwestern states and ...